Your session is about to expire
← Back to Search
Procedure
MicroPulse TransScleral CycloPhotoCoagulation for Glaucoma
N/A
Waitlist Available
Led By Sandra F Sieminski, MD
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2years
Awards & highlights
Study Summary
This study is evaluating whether a new laser treatment may help reduce pressure in the eye for individuals with glaucoma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in intraocular pressure measurements between baseline and postoperative followup visits
Secondary outcome measures
Changes in number of medications between baseline and postoperative followup visits
Changes in visual acuity measurements measured using a Snellen Vision Chart between baseline and postoperative followup visits
Rate of post surgical complications
Trial Design
3Treatment groups
Experimental Treatment
Group I: Constant power but varying dwell time and durationExperimental Treatment1 Intervention
The laser power will be constant but the laser dwell time and duration will be varied for patients
Group II: Constant dwell time but varying power and durationExperimental Treatment1 Intervention
The laser dwell time will be constant but the laser power and duration will be varied for patients
Group III: Constant duration but varying dwell time and powerExperimental Treatment1 Intervention
The laser duration will be constant but the laser dwell time and power will be varied for patients
Find a Location
Who is running the clinical trial?
State University of New York at BuffaloLead Sponsor
246 Previous Clinical Trials
49,482 Total Patients Enrolled
3 Trials studying Glaucoma
450 Patients Enrolled for Glaucoma
IRIDEX CorporationUNKNOWN
2 Previous Clinical Trials
277 Total Patients Enrolled
1 Trials studying Glaucoma
250 Patients Enrolled for Glaucoma
Sandra F Sieminski, MDPrincipal InvestigatorRoss Eye Institute
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger